Multiple Rising Inhalative Doses of BI 1744 CL in Healthy Male Volunteers
NCT02172105
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BI 1744 CL
DRUG:
Placebo
Sponsor
Boehringer Ingelheim